Impact of national-scale targeted point-of-care symptomatic lateral flow testing on trends in COVID-19 infections, hospitalisations and deaths during the second epidemic wave in Austria (REAP3)

Peer Review reports

Original Submission
3 Jul 2022	Submitted	Original manuscript
4 Oct 2022	Reviewed	Reviewer Report
8 Nov 2022	Reviewed	Reviewer Report
30 Nov 2022	Author responded	Author comments - Jasmina Panovska-Griffiths
Resubmission - Version 2
30 Nov 2022	Submitted	Manuscript version 2
30 Nov 2022	Author responded	Author comments - Jasmina Panovska-Griffiths
Resubmission - Version 3
30 Nov 2022	Submitted	Manuscript version 3
12 Dec 2022	Reviewed	Reviewer Report
5 Jan 2023	Author responded	Author comments - Jasmina Panovska-Griffiths
Resubmission - Version 4
5 Jan 2023	Submitted	Manuscript version 4
28 Jan 2023	Reviewed	Reviewer Report
23 Feb 2023	Author responded	Author comments - Jasmina Panovska-Griffiths
Resubmission - Version 5
23 Feb 2023	Submitted	Manuscript version 5
28 Feb 2023	Author responded	Author comments - Jasmina Panovska-Griffiths
Resubmission - Version 6
28 Feb 2023	Submitted	Manuscript version 6
Publishing
3 Mar 2023	Editorially accepted
16 Mar 2023	Article published	10.1186/s12889-023-15364-w

Back to article page